Univalor-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Univalor - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013207
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Univalor is a university technology transfer organization which optimizes research outcomes by commercializing the technological innovations of researchers from academic institutions and health centers. The organization offers researcher services such as evaluating the technical feasibility and commercial potential of technology; protecting intellectual property; establishing a development strategy; developing requests for financing; creating partnerships; and transferring technology to industries. It determines the ideal form of technology transfer, which includes licensing, option, transfer of knowledge or material, creation of a spin-off company, and others. The organization works with research offices of universities, research laboratories and their affiliated health centers to ensure implementation of technology transfer agreements. Univalor is headquartered in Montreal, Quebec, Canada.

Univalor – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Univalor, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Univalor, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Univalor, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Univalor, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Univalor, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Univalor, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Liphorus Pharma Raises USD5.6 Million in Series A Financing 10
Partnerships 11
Univalor Partners with Centre de recherche du Centre hospitalier de l’Universite de Montreal and Neomed Institute 11
Licensing Agreements 12
SemaThera Enters into Licensing Agreement with Univalor 12
Mperia Therapeutics Enters into Licensing Agreement with Univalor 13
Univalor – Key Competitors 14
Univalor – Key Employees 15
Univalor – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Univalor, Pharmaceuticals & Healthcare, Key Facts 2
Univalor, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Univalor, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Univalor, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Univalor, Deals By Therapy Area, 2011 to YTD 2017 8
Univalor, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Liphorus Pharma Raises USD5.6 Million in Series A Financing 10
Univalor Partners with Centre de recherche du Centre hospitalier de l'Universite de Montreal and Neomed Institute 11
SemaThera Enters into Licensing Agreement with Univalor 12
Mperia Therapeutics Enters into Licensing Agreement with Univalor 13
Univalor, Key Competitors 14
Univalor, Key Employees 15

★海外企業調査レポート[Univalor-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BAM Nuttall Ltd:企業の戦略的SWOT分析
    BAM Nuttall Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Analytik Jena AG:医療機器:M&Aディール及び事業提携情報
    Summary Analytik Jena AG (Analytik Jena), a subsidiary of Endress+Hauser AG is a provider of instruments and products for analytical measuring technology and life science. The company’s major products include atomic spectrometers, optical emission spectroscopy devices, mass spectrometers, mercury an …
  • AngloGold Ashanti Ltd:企業の戦略・SWOT・財務情報
    AngloGold Ashanti Ltd - Strategy, SWOT and Corporate Finance Report Summary AngloGold Ashanti Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Plus Therapeutics Inc (PSTV):企業の財務・戦略的SWOT分析
    Plus Therapeutics Inc (PSTV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • AbbVie Inc (ABBV)-医療機器分野:企業M&A・提携分析
    Summary AbbVie Inc (AbbVie) is a research-based biopharmaceutical company that carries out the research, development, manufacture and commercialization of advanced therapies to treat complex and serious diseases. The company focuses on providing drugs in immunology, cancer, neuroscience and virology …
  • Align Technology Inc (ALGN):企業の財務・戦略的SWOT分析
    Align Technology Inc (ALGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Amphenol Corp (APH):企業の財務・戦略的SWOT分析
    Amphenol Corp (APH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Fujicco Co Ltd:企業の戦略・SWOT・財務情報
    Fujicco Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Fujicco Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Bank of Panhsin:企業の戦略・SWOT・財務情報
    Bank of Panhsin - Strategy, SWOT and Corporate Finance Report Summary Bank of Panhsin - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • EMCORE Corporation (EMKR):企業の財務・戦略的SWOT分析
    EMCORE Corporation (EMKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Scripps Health-製薬・医療分野:企業M&A・提携分析
    Summary Scripps Health (Scripps) is a non-profit healthcare organization, which provides healthcare services including primary care and urgent and emergency care services; preventive services and wellness screening services in San Diego County in the US. Scripps offers specialized medical care with …
  • Atrium Innovations Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Atrium Innovations Inc (Atrium) is a provider of science-based natural health products. The company develops, manufactures and markets nutritional and dietary supplements. Its major products include minerals, vitamins and specialized products such as enzymes and probiotics. Atrium markets it …
  • Axis Bank Ltd (AXISBANK):企業の財務・戦略的SWOT分析
    Axis Bank Ltd (AXISBANK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • VTT Technical Research Centre of Finland-製薬・医療分野:企業M&A・提携分析
    Summary VTT Technical Research Centre of Finland (VTT) is a research and technology center that offers development services. The center provides research services on bioeconomy and circular economy, health and wellbeing, digital society, low carbon energy, smart industry, sustainable and smart city, …
  • Rosoboronexport:企業の戦略・SWOT・財務情報
    Rosoboronexport - Strategy, SWOT and Corporate Finance Report Summary Rosoboronexport - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Del Frisco’s Restaurant Group, Inc.:企業の戦略・SWOT・財務情報
    Del Frisco’s Restaurant Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Del Frisco’s Restaurant Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Atkore International Group Inc (ATKR):企業の財務・戦略的SWOT分析
    Atkore International Group Inc (ATKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Mediaset SpA (MS)
    Mediaset SpA (MS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Biolase, Inc. (BIOL)-医療機器分野:企業M&A・提携分析
    Summary Biolase, Inc. (Biolase) is medical device company which develops, manufactures, markets and sells dental lasers and related products. It also distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners. The company offers two categories of laser s …
  • Amazon.com Inc (AMZN):企業の財務・戦略的SWOT分析
    Amazon.com Inc (AMZN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆